By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pluristem Therapeutics 

New York  New York    U.S.A.
Phone: n/a Fax: n/a



Company News
Pluristem Therapeutics (PSTI) To Present At The International Congress Of Radiation Research And Chair Two Panels At The Annual Meeting Of The International Society For Cellular Therapy 5/27/2015 7:58:49 AM
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 5/26/2015 6:42:58 AM
Pluristem Therapeutics (PSTI) To Conduct Conference At Tel Aviv Stock Exchange To Review Regulatory Progress And Company Strategy 5/19/2015 10:44:34 AM
Significant Progress For Pluristem Therapeutics (PSTI): PLX Cells Were Selected For European Medicines Agency's Adaptive Pathways Pilot Project 5/18/2015 10:21:20 AM
Pluristem Therapeutics (PSTI)'s PLX Cells One Step Closer To Entering Japan's Accelerated Pathway For Regenerative Medicine 5/13/2015 12:54:40 PM
Pluristem Therapeutics (PSTI) To Hold Symposium On Therapeutic Angiogenesis For Peripheral Arterial Occlusive Disease At European Society For Vascular Medicine In Berlin, Germany 5/7/2015 12:39:12 PM
Pluristem Therapeutics (PSTI) To Present At Five Industry And Finance Conferences In May 5/4/2015 10:56:22 AM
Pluristem Therapeutics (PSTI)'s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan 4/20/2015 7:41:25 AM
Celgene (CELG), Mesoblast (MSB.AX) $45M Deal "Speaks Volumes" About Big Pharma's Cell Therapy Plans, Says Pluristem Therapeutics (PSTI) 4/14/2015 6:27:36 AM
Pluristem Therapeutics (PSTI) Announces Key Strategic Objectives For Development Of PLX-R18 In Hematopoietic Indications 3/24/2015 7:24:19 AM